Jeremy Mauldin

776 citations
19 papers · 559 indexed · h-index 12
Topics
Virus-based gene therapy research (6 papers)Virology and Viral Diseases (6 papers)Drug Transport and Resistance Mechanisms (5 papers)
Partner nations
United StatesItalyJapan

In The Last Decade

Jeremy Mauldin

18 papers receiving 544 citations

Peers

Jeremy Mauldin
Comparison fields: 5 of 59
  • Surgery 200
  • Epidemiology 186
  • Molecular Biology 161
  • Oncology 144
  • Genetics 78
Replace Anita Parmigiani with:
Anita Parmigiani United States
Heekyong Bae United States
Weihua Pan China
Lee-Ann Van de Velde United States
Elazar Rabbani Israel
Vanessa Gauttier France
Nerea Razquin Spain
Chakib Boussahmain United States
Minghuan Zheng China
Takashi Ohkawa Japan
Jeremy Mauldin relative to Anita Parmigiani United States Anita Parmigiani's profile →
Citations per field
00.5×5.7×
Anita Parmigiani · 1×
Citations per year

Countries citing papers authored by Jeremy Mauldin

Since Specialization
Citations

This map shows the geographic impact of Jeremy Mauldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Mauldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Mauldin more than expected).

Fields of papers citing papers by Jeremy Mauldin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Mauldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Mauldin. The network helps show where Jeremy Mauldin may publish in the future.

Co-authorship network of co-authors of Jeremy Mauldin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Mauldin. A scholar is included among the top collaborators of Jeremy Mauldin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Mauldin. Jeremy Mauldin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 20
2 2
3 5
4 1
5 9
6 30
7 26
8 3
9 99
10 19
11 0
12 82
13 50
14 32
15 56
16 32
17 1
18 32
19 60

About Jeremy Mauldin

Jeremy Mauldin is a scholar working on Biotechnology, Dermatology and Oncology, having authored 19 papers that have together received 559 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Virology and Viral Diseases (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Hepatology (74 citations), Biotechnology (52 citations) and Epidemiology (186 citations). Jeremy Mauldin has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Catherine C. Hedrick, Suseela Srinivasan, Steven A. Rubin, Kathryn M. Carbone, Anny Mulya, Coleen A. McNamara, Marcus D. Skaflen, Konstantin Chumakov, John S. Parks and Alan Daugherty. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026